Pollen Cross-Reactivity: A Primer for Allergy Specialists
DOI:
https://doi.org/10.58931/cait.2024.4270Abstract
There are over 400,000 land-based plant species that comprise our biodiverse habitat. Only a small subset of those plant species satisfies Thommen’s postulates, classifying them as allergens. The number of allergenic species, however, remains so vast that it is prohibitive to both test and treat for all relevant species within a geographical region. Allergy specialists have a valuable tool that can be used to help simplify the management of allergic patients: cross-reactivity.
Cross-reactivity is the ability for an allergen to induce an IgE-mediated response, regardless of previous exposure. Allergens are a complex milieu of proteins, some of which have allergic potential while others do not. A number of proteins are conserved across allergen species. When exposure to these conserved proteins occurs, the immune system recognizes them in a similar manner. For homologous or cross-reactive allergenic proteins, this conserved molecular recognition initiates the allergic cascade. Allergen characterization is critical to the understanding of cross-reactivity. Characterization, in this context, refers to the protein make-up of a particular allergen. The process of allergen characterization began in 1962 with the discovery of antigen E, the first identified allergenic protein. Antigen E, commonly known as Amb a 1, is an allergenic protein in ragweed, and is the primary sensitizing protein for ragweed allergy sufferers. These primary sensitizers are referred to as major allergens and can be defined as such when >50% of the allergic patient population is sensitized to them. An entire branch of research arose from this discovery, which has allowed for major advances to be made in the understanding of cross‑reactive relationships among allergen species. Cross‑reactivity is not limited to homologous major allergen expression. Rather, minor allergens and panallergens, though less clinically relevant, play a similar role in cross‑reactive relationships. This primer will explore the science behind cross‑reactivity, as well as provide a general overview of the cross‑reactive relationships that have been defined for plant allergens found across North America.
References
Aalberse RC. Assessment of allergen cross-reactivity. Clinical and molecular allergy : CMA. 2007;5:2. doi:10.1186/1476-7961-5-2
Pomes A, Davies JM, Gadermaier G, Hilger C, Holzhauser T, Lidholm J, et al. WHO/IUIS Allergen Nomenclature: providing a common language. Mol Immunol. 2018;100:3-13. doi:10.1016/j.molimm.2018.03.003
Kleine-Tebbe J, Ackermann-Simon J, Hanf G. Molecular allergy diagnosis using pollen marker allergens and pollen panallergens: five patterns seen in multiple test reactions to pollen extracts. Allergol Select. 2021;5:180-186. doi:10.5414/alx02238e
Bublin M, Breiteneder H. Cross-reactivities of non-homologous allergens. Allergy. 2020;75(5):1019-1022. doi:10.1111/all.14120
Sharma E, Vitte J. A systematic review of allergen cross-reactivity: translating basic concepts into clinical relevance. J Allergy Clin Immunol Glob. 2024;3(2):100230. doi:10.1016/j.jacig.2024.100230
Hejl C, Wurtzen PA, Kleine-Tebbe J, Johansen N, Broge L, Ipsen H. Phleum pratense alone is sufficient for allergen-specific immunotherapy against allergy to Pooideae grass pollens. Clin Exp Allergy. 2009;39(5):752-759. doi:10.1111/j.1365-2222.2008.03195.x
Johansen N, Weber RW, Ipsen H, Barber D, Broge L, Hejl C. Extensive IgE cross-reactivity towards the Pooideae grasses substantiated for a large number of grass-pollen-sensitized subjects. Int Arch Allergy Immunol. 2009;150(4):325-334. doi:10.1159/000226233
Biedermann T, Kuna P, Panzner P, Valovirta E, Andersson M, de Blay F, et al. The SQ tree SLIT-tablet is highly effective and well tolerated: results from a randomized, double-blind, placebo-controlled phase III trial. J Allergy Clin Immunol . 2019;143(3):1058-1066 e1056. doi:10.1016/j.jaci.2018.12.1001
Zbîrcea LE, Buzan MR, Grijincu M, Babaev E, Stolz F, Valenta R, et al. Relationship between IgE levels specific for ragweed pollen extract, amb a 1 and cross-reactive allergen molecules. Int J Mol Sci. 2023;24(4). doi:10.3390/ijms24044040
McKenna OE, Asam C, Araujo GR, Roulias A, Goulart LR, Ferreira F. How relevant is panallergen sensitization in the development of allergies? Pediatr Allergy Immunol. 2016;27(6):560-568. doi:10.1111/pai.12589
Ramirez DA, Andrews CP, Rather CG, Jacobs RL. Responsiveness to timothy grass pollen in individuals without known natural exposure in an allergen challenge chamber. Ann Allergy Asthma Immunol. 2015;114(3):226-232. doi:10.1016/j.anai.2014.11.006
Weber RW. Assessing cross-reactivity in allergen immunotherapy. Allergy Asthma Proc. 2022;43(4):314-321. doi:10.2500/aap.2022.43.210112
Plunkett GA, Barber D, Villalobos EM, Jacobs JS, Hallett JS, Mostofi T, et al. Prevalence of IgE Specific to Profilin in a Texas and California Population. J Allergy Clin Immunol. 2013;131(2):AB111. doi:10.1016/j.jaci.2012.12.1067
Nelson HS. The use of standardized extracts in allergen immunotherapy. J Allergy Clin Immunol. 2000;106(1 Pt 1):41-45. doi:10.1067/mai.2000.107197
van Nunen SA, Burk MB, Burton PK, Ford G, Harvey RJ, Lozynsky A, et al. 5-grass-pollen SLIT effectiveness in seasonal allergic rhinitis: impact of sensitization to subtropical grass pollen. World Allergy Organ J. 2022;15(2):100632. doi:10.1016/j.waojou.2022.100632
Maloney J, Bernstein DI, Nelson H, Creticos P, Hebert J, Noonan M, et al. Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial. Ann Allergy Asthma Immunol. 2014;112(2):146-153 e142. doi:10.1016/j.anai.2013.11.018
Couroux P, Ipsen H, Stage BS, Damkjaer JT, Steffensen MA, Salapatek AM, et al. A birch sublingual allergy immunotherapy tablet reduces rhinoconjunctivitis symptoms when exposed to birch and oak and induces IgG(4) to allergens from all trees in the birch homologous group. Allergy. 2019;74(2):361-369. doi:10.1111/all.13606
Ansotegui IJ, Melioli G, Canonica GW, Caraballo L, Villa E, Ebisawa M, et al. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper. World Allergy Organ J. 2020;13(2):100080. doi:10.1016/j.waojou.2019.100080
Buzan MR, Zbîrcea LE, Gattinger P, Babaev E, Stolz F, Valenta R, et al. Complex IgE sensitization patterns in ragweed allergic patients: Implications for diagnosis and specific immunotherapy. Clin Transl Allergy. 2022;12(7):e12179. doi:10.1002/clt2.12179
Wopfner N, Gadermaier G, Egger M, Asero R, Ebner C, Jahn-Schmid B, et al. The spectrum of allergens in ragweed and mugwort pollen. Int Arch Allergy Immunol. 2005;138(4):337-346. doi:10.1159/000089188
Perrick D, Stafford CT, Armstrong E, DuRant RH. Modification of the fluorescent allergosorbent test as an inhibition assay for determination of cross-reactivity among aeroallergens. J Allergy Clin Immunol. 1991;87(1 Pt 1):98-103. doi:10.1016/0091-6749(91)90218-d
Tehrani M, Sankian M, Assarehzadegan MA, Falak R, Jabbari F, Varasteh A. Immunochemical characterization of Amaranthus retroflexus pollen extract: extensive cross-reactive allergenic components among the four species of Amaranthaceae/Chenopodiaceae. Iran J Allergy Asthma Immunol. 2010;9(2):87-95.
Villalba M, Barderas R, Mas S, Colás C, Batanero E, Rodríguez R. Amaranthaceae pollens: review of an emerging allergy in the mediterranean area. J Investig Allergol Clin Immunol. 2014;24(6):371-381; quiz 372 p preceding 382.
Izmailovich M, Semenova Y, Abdushukurova G, Mukhamejanova A, Dyussupova A, Faizova R, et al. Molecular aspects of allergen-specific immunotherapy in patients with seasonal allergic rhinitis. Cells. 2023;12(3). doi:10.3390/cells12030383
